Marcum Wealth LLC Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Marcum Wealth LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,574 shares of the medical equipment provider’s stock after selling 115 shares during the period. Marcum Wealth LLC’s holdings in Intuitive Surgical were worth $1,344,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. Finally, DT Investment Partners LLC boosted its holdings in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $539.75 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23. The firm’s 50-day moving average is $536.58 and its 200-day moving average is $495.83. The company has a market cap of $192.25 billion, a P/E ratio of 86.78, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Truist Financial raised their target price on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.